A phase II study to investigate combination of chemo-radiotherapy with metformin in patients with Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC).

一项 II 期研究，旨在调查放化疗与二甲双胍联合治疗局部晚期非小细胞肺癌 (LA-NSCLC) 患者。

• 批准号: 282345
• 负责人: Tsakiridis Theodoros
• 金额: $ 41.42万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2017-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=282345&lang=en
• 关键词: Biomarker; Cancer Biology; Chemotherapy; Clinical Trial; Drug Development; Lung Cancer; Metformin; Radiotherapy

It is estimated that in 2012 in Canada 25,600 people were diagnosed with lung cancer and more than 20,000 died from it. More than 80% of lung cancer patients are diagnosed with NSCLC which often presents at advanced stages in patients with poor health who

据估计，2012年加拿大有25,600人被诊断患有肺癌，超过20,000人死于肺癌。超过80%的肺癌患者被诊断为非小细胞肺癌，通常在健康状况不佳的患者中出现在晚期